RECRUITING

Bone Stimulator for Spondylolysis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Official Title

The Efficacy of Bone Stimulator in Treatment and Return-to-Sport for Spondylolysis

Quick Facts

Study Start:2025-09
Study Completion:2029-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06666608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:16 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
  2. * Patients who plan to attend prescribed physical therapy
  3. * Patients who participate in a regular sport whether that be professional, collegiate or recreational
  1. * Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
  2. * Patients with contraindications to bone stimulator therapy
  3. * Patients with pacemaker and implantable cardioverter defibrillator
  4. * Patients with previous spine surgery
  5. * Patients with metabolic bone conditions
  6. * Patients who use nicotine products
  7. * Vulnerable populations
  8. * Non-English speaking services

Contacts and Locations

Study Contact

Haley Goble, MHA
CONTACT
713-441-3930
hmgoble@houstonmethodist.org

Principal Investigator

Mark Prasarn, MD
PRINCIPAL_INVESTIGATOR
The Methodist Hospital Research Institute

Study Locations (Sites)

Houston Methodist Hospital
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The Methodist Hospital Research Institute

  • Mark Prasarn, MD, PRINCIPAL_INVESTIGATOR, The Methodist Hospital Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09
Study Completion Date2029-12

Study Record Updates

Study Start Date2025-09
Study Completion Date2029-12

Terms related to this study

Additional Relevant MeSH Terms

  • Spondylolysis
  • Symptomatic Spondylolysis
  • Athletes